LP2
LDL, human
ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
| 容量 | カタログ番号 | 在庫状況 | 単価 |
|---|
この商品について
UNSPSC Code:
12352202
NACRES:
NA.41
eCl@ss:
32160405
現在、価格および在庫状況を閲覧できません。
biological source
human
Quality Level
assay
>95% (SDS-PAGE)
form
liquid
manufacturer/tradename
Chemicon®
concentration
4.56 mg/mL protein
General description
LDL constitutes 50% of the total lipoprotein mass in plasma and is the major carrier of cholesterol and cholesteryl esters. LDL levels strongly correlate with coronary heart disease.
Molecular weight = 2,300,000. Da
Composition = 78-80% lipid, 22-20% protein
Density = 1.02 - 1.063 g/mL
Molecular weight = 2,300,000. Da
Composition = 78-80% lipid, 22-20% protein
Density = 1.02 - 1.063 g/mL
MOLECULAR WEIGHT:
2,300,000
DENSITY:
1.02 - 1.063 g/mL
2,300,000
DENSITY:
1.02 - 1.063 g/mL
Product Source: Human plasma tested negative for HBsAg and HIV-I, HIV-II, HBc and Hepatitis C antibodies. All blood products should be treated as potentially infectious.
Physical form
Liquid in 150 mM NaCl, pH 7.4 with 0.01% EDTA. Prepared by sequential flotation ultracentrifugation technique using KBr for density adjustments. Protein is determined by modified Lowry method using BSA as the standard. COMPOSITION: 78-80% lipid, 22-20% protein; CHOLESTROL: 5/44 mg/mL (varies with lot) TRIGLYCERIDE: 1/67 mg/mL (varies with lot)
Preparation Note
Maintain at 2-8ºC in undiluted aliquots for up to 3 months. Do Not Freeze. All blood products should be treated as potentially infectious.
Analysis Note
≥95% of total lipoprotein content as determined by electrophoresis using a SPIFE Cholesterol gel for lipids and SDS-PAGE for proteins.
Other Notes
Replaces: LP2-10MG
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
1 of 1
当該品目 | |||
|---|---|---|---|
| biological source human | biological source human | biological source human plasma | biological source - |
| assay >95% (SDS-PAGE) | assay >95% | assay - | assay ≥95% (of total lipoprotein content, electrophoresis) |
| form liquid | form liquid | form lyophilized powder | form liquid |
| manufacturer/tradename Chemicon® | manufacturer/tradename Chemicon® | manufacturer/tradename - | manufacturer/tradename Calbiochem® |
| Quality Level 100 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
| concentration 4.56 mg/mL protein | concentration - | concentration - | concentration - |
保管分類
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
LP2-2MG:
jan
試験成績書（COA）
製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
グローバルトレードアイテム番号
| カタログ番号 | GTIN |
|---|---|
| LP2-2MG | 04053252728587 |